Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fulminant hepatic failure.

A O Shakil1, G V Mazariegos, D J Kramer

  • 1Thomas E. Starzl Transplantation Institute, Pittsburgh, Pennsylvania, USA. obaid@med.pitt.edu

The Surgical Clinics of North America
|March 12, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi-Site Study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Influence of anthropometric features on graft diameter in ACL reconstruction.

Archives of orthopaedic and trauma surgery·2012
Same author

Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: a case series.

Pediatric transplantation·2010
Same author

Intestine transplantation in the United States, 1999-2008.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
Same author

Long-term management of the liver transplant patient: recommendations for the primary care doctor.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Same author

Liver and intestine transplantation in the United States 1998-2007.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
See all related articles

Fulminant hepatic failure (FHF) is a severe liver condition with high mortality. Advanced treatments like liver transplantation and artificial liver support offer hope for patient survival.

Area of Science:

  • Hepatology
  • Critical Care Medicine
  • Transplantation Surgery

Background:

  • Fulminant hepatic failure (FHF) presents a significant clinical challenge due to its varied etiologies and high mortality rate.
  • Key clinical features include rapid onset jaundice, hepatic encephalopathy, and multiorgan failure, necessitating urgent medical intervention.

Purpose of the Study:

  • To outline the critical management strategies for patients diagnosed with FHF.
  • To highlight the role of liver transplantation and emerging artificial liver support systems in improving patient outcomes.

Main Methods:

  • Review of current medical literature and clinical practice guidelines for FHF management.
  • Analysis of the impact of liver transplantation and artificial liver support devices on patient survival and prognosis.

Related Experiment Videos

Main Results:

  • FHF management requires a multidisciplinary approach with intensive patient monitoring.
  • Liver transplantation is a life-saving option for eligible patients.
  • Artificial liver support devices show potential in extending the therapeutic window for native liver regeneration or transplantation.

Conclusions:

  • Successful management of FHF hinges on early prognostication and timely access to donor livers.
  • Artificial liver support technologies may significantly improve the chances of recovery or successful transplantation in FHF patients.